TDBOF yields 2.52% · PFE yields 6.13%● Live data
📍 TDBOF pulled ahead of the other in Year 1
Combined, TDBOF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TDBOF + PFE for your $10,000?
Toyota Boshoku Corporation manufactures and sells automotive interior systems and products, automotive filter and power train equipment components, automotive components, and fabric goods in Japan, the United States, rest of Asia, Oceania, China, Europe, and Africa. The company offers automobile and aircraft seats, and door trims; headliners, such as molded headliners for a panorama roof, overhead console illumination, and grab handles; and floor carpets, package trays, tonneau covers, and deck boards, as well as exterior components consisting of bumpers, fender liners, and engine undercovers. It also provides filter products, including air and oil filters; and anti-allergen and deodorizing, dust and pollen removal, and anti-bacterial cabins, as well as clean air filters. In addition, the company offers air induction part products, such as air induction systems and cleaners, intake manifolds, oil mist separators, timing chain covers, and cylinder head covers; and fuel cell part products comprising air filter for fuel cell vehicles, ion exchangers, and separators, as well as anti-droplet partition and weets. Further, it provides aircraft and railway seats; and textile components comprising seat fabrics, curtain-shield airbags, and seatbelt webbings. The company was founded in 1918 and is based in Kariya, Japan.
Full TDBOF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.